New Gate Capital Overview
New Gate Capital's network provides a unique backdoor into the top investment opportunities in Israel at the founders terms. The proprietary deal flow of companies trusted by the wisdom of leading VCs and corporates provides its partners with unique access to closed deals with proper valuations.
Latest News
Growth-Negative
Preliminary AgFunder data point to 78% decline in cultivated meat funding in 2023; investors blame 'general risk aversion'
The article discusses the challenges faced by cultivated meat and seafood companies in raising capital. Funding for these startups peaked at $989 million in 2021, dipped to $807 million in 2022, and dropped sharply to $177 million in 2023. Companies like Finless Foods are rumored to be making significant cutbacks, while others like New Age Eats have closed due to lack of funds. The current funding environment for cellular agriculture is not favorable, with high-interest rates posing a significant challenge. The article suggests that government support is essential to kickstart the cultivated meat industry.
InvestmentLayoffs
growth-positive
Cydome secures $8 million Series A to prevent maritime cyber threats | CTech
Israeli startup Cydome, which develops maritime cybersecurity solutions, has raised $8 million in a Series A funding round. The round was led by U.S.-based 2.0 Ventures, with participation from MD One Ventures, Camden Capital, Pointman UK, New Gate Capital, and existing investor VentureIsrael. The funds will be used to expand Cydomes market presence and operations globally. Cydomes solution is designed to address maritime needs, covering asset, vessel and fleet visibility and real-time protection, along with regulation compliance.
InvestmentExpand
growth-positive
Maolac NPD: Gut support and anti-inflammatory activity targeted with AI and breastmilk
Maolac, an Israeli start-up, has launched two new products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, which are developed using a unique algorithm that combines computational biology and generative AI. The products are based on proteins from bovine colostrum but have a high similarity to human breastmilk. The company is initially targeting the US and Europe, but aims to have a global reach. Maolac is also investing heavily in upgrading its AI capabilities to provide more targeted protein-based compositions from plant and animal sources.
CustomersExpand
growth-positive
Maolac combines AI with breastmilk to make tummies feel better
Israeli bio-food-tech company Maolac has introduced new products that combine traditional components with advanced technology: breastmilk and AI. The products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, have been developed using artificial intelligence and the companys “Maoreka” algorithm. The global market for immune-boosting foods is projected to reach $46.9 billion by 2030, and Maolacs approach is expected to bring significant changes. The company aims to empower individuals to lead healthier lives by providing affordable and high-quality nutritional products that support their well-being.
CustomersInvestment
growth-positive
הבשר המתורבת לוקח צעד קדימה - מיטאפורה מגייסת 5 מיליון דולר
Israeli food tech company Meat-Tech has announced a $5 million investment from a private investor, led by New Gate Capital, at a company valuation of $20 million. The funds will be used to complete the development of an efficient and cheap production process for cultured meat. The company, founded by Professor Marcel Mechlov and businessman Shmuel Yanai, has developed a novel production method that grows cells on edible plant protein carriers. The company has managed to produce lab-grown meat at low cost, and is in the final stages of completing a scale-up that will enable industrial-scale production.
Investment
Team Members
3
Web & Social Links
| Website | www.newgate.capital/ |
Locations
Rothschild Boulevard 3, Tel Aviv-Yafo, Israel
Jaffa St 204, Jerusalem, Israel
302 Putney Bridge Rd, London SW15 2PD, UK
Photos & Videos
3 item(s)
New Gate Capital Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Tags (9)
cyber-threat-analysiscyber-intelligencedeep-learningindustry-4.0energytechartificial-intelligencegamesfoodtechcyber-securityNew Gate Capital Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
New Gate Capital Lifecycle
New Gate Capital News
7 articles
Growth-Negative
Preliminary AgFunder data point to 78% decline in cultivated meat funding in 2023; investors blame 'general risk aversion'
The article discusses the challenges faced by cultivated meat and seafood companies in raising capital. Funding for these startups peaked at $989 million in 2021, dipped to $807 million in 2022, and dropped sharply to $177 million in 2023. Companies like Finless Foods are rumored to be making significant cutbacks, while others like New Age Eats have closed due to lack of funds. The current funding environment for cellular agriculture is not favorable, with high-interest rates posing a significant challenge. The article suggests that government support is essential to kickstart the cultivated meat industry.
InvestmentLayoffs
growth-positive
Cydome secures $8 million Series A to prevent maritime cyber threats | CTech
Israeli startup Cydome, which develops maritime cybersecurity solutions, has raised $8 million in a Series A funding round. The round was led by U.S.-based 2.0 Ventures, with participation from MD One Ventures, Camden Capital, Pointman UK, New Gate Capital, and existing investor VentureIsrael. The funds will be used to expand Cydomes market presence and operations globally. Cydomes solution is designed to address maritime needs, covering asset, vessel and fleet visibility and real-time protection, along with regulation compliance.
InvestmentExpand
growth-positive
Maolac NPD: Gut support and anti-inflammatory activity targeted with AI and breastmilk
Maolac, an Israeli start-up, has launched two new products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, which are developed using a unique algorithm that combines computational biology and generative AI. The products are based on proteins from bovine colostrum but have a high similarity to human breastmilk. The company is initially targeting the US and Europe, but aims to have a global reach. Maolac is also investing heavily in upgrading its AI capabilities to provide more targeted protein-based compositions from plant and animal sources.
CustomersExpand
growth-positive
Maolac combines AI with breastmilk to make tummies feel better
Israeli bio-food-tech company Maolac has introduced new products that combine traditional components with advanced technology: breastmilk and AI. The products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, have been developed using artificial intelligence and the companys “Maoreka” algorithm. The global market for immune-boosting foods is projected to reach $46.9 billion by 2030, and Maolacs approach is expected to bring significant changes. The company aims to empower individuals to lead healthier lives by providing affordable and high-quality nutritional products that support their well-being.
CustomersInvestment
growth-positive
הבשר המתורבת לוקח צעד קדימה - מיטאפורה מגייסת 5 מיליון דולר
Israeli food tech company Meat-Tech has announced a $5 million investment from a private investor, led by New Gate Capital, at a company valuation of $20 million. The funds will be used to complete the development of an efficient and cheap production process for cultured meat. The company, founded by Professor Marcel Mechlov and businessman Shmuel Yanai, has developed a novel production method that grows cells on edible plant protein carriers. The company has managed to produce lab-grown meat at low cost, and is in the final stages of completing a scale-up that will enable industrial-scale production.
Investment
growth-positive
New Gate Capital מטאפורה מגייסת 5 מיליון דולר בהובלת
Generation Capital is planning to change its management agreement so that management fees will be significantly reduced. This is in response to criticism and is intended to create a correlation between the return to shareholders and the compensation to the management company.
Management Changes
5M Round announced
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
New Gate Capital Internal
Recent Updates
Alex Shilman
· alex@shilmanalex.com · Manual · 2024-02-15 11:38:50.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-08 12:18:52.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:24:54.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 14:19:40.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:30:41.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:36:19.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:25:50.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-07-28 09:37:34.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-03-09 09:48:49.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-03-09 09:45:41.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:30:43.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:24:54.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-12-03 10:10:03.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:25:50.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:25:58.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2023-12-06 08:20:11.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-07-28 09:41:36.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-12-03 10:28:02.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:24:54.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:30:59.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-03-09 09:47:58.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2024-12-17 13:39:18.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-03-06 13:25:24.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-12-11 15:16:40.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-12-03 10:28:02.000000
Alex Shilman
· alex@shilmanalex.com · Automatic · 2024-02-15 11:38:53.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-03-09 09:43:30.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2024-02-13 17:23:41.000000
Alex Shilman
· alex@shilmanalex.com · Manual · 2023-12-03 10:10:11.000000
Doron Bobman
· doron.b@sncentral.org · Manual · 2025-07-28 09:41:33.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 64/100 |
| Missing | product stage, sector, number of employees, business model, tag line, funding rounds, markets |
| BI Verification | Ortal Wein |
| Registrar ID | 516587854 |
| Phone | +972547229020 |
| Creator | Alexander Shilman |
| Creator email | alexander.shilman@gmail.com |
| Last updater | Alex Shilman |
| Updater email | alex@shilmanalex.com |
| Last update | 2023-03-09T00:00:00.000Z |
| Created | 2021-11-01T00:00:00.000Z |